Eleftheria N. Finger

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents

P.H. Hutson, Eleftheria N. Finger, Brian C. Magliaro et al. · Neuropharmacology · 2011 · 139 citations

Synaptic Plasticity, Medicine, Synaptic Transmission +9

Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration

Sophie Parmentier‐Batteur, Julie A. O’Brien, Scott M. Doran et al. · Neuropharmacology · 2010 · 63 citations

Differential Effects, Neurophysiology, Medicine +10

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice

Anthony J. Roecker, Melissa S. Egbertson, Kristen L. Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 45 citations · Full text

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model

Joseph E. Pero, Michael Rossi, Hannah D. G. F. Lehman et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 36 citations · Full text

Attenuation of scratch‐induced reactive astrogliosis by novel EphA4 kinase inhibitors

Sophie Parmentier‐Batteur, Eleftheria N. Finger, Raghu Krishnan et al. · Journal of Neurochemistry · 2011 · 26 citations